Headlines

Merck KGgA collaborates with Exscientia plc in deal worth up to $674M

Exscientia plc will receive an upfront cash payment of $20 million from Merck KGaA, Darmstadt, Germany, as the companies collaborate plus potential payments of up to $674 million in aggregate.

Positive, rapid and sustained effects on MDD patients treated with Relmada anti-depressant

Relmada Therapeutics, Inc. has announced rapid and sustained effects of an anti-depressant in patients with major depressive disorders (MDD).

Paid for and content provided by DHL Supply Chain

Control Towers in clinical trials: Harnessing logistics best practice to address pain points in the clinical trials market

There are many logistical obstacles faced by pharmaceutical companies. A Control Tower can provide quality controls built into processes from the outset.

Mural Health raises $8 million in seed funding to grow platform modernizing clinical trials

Mural Health Technologies, Inc. has raised $8 million in seed funding for the growth of its Mural link platform it says is aimed at ‘modernizing the clinical trial experience for both patients and caregivers’.

SMi System's single-molecule imaging technology first to be protected by patent

Therapeutic candidates and patient samples can be analyzed ‘in a fraction of the time it would normally take’ thanks to newly patented single-molecule imaging technology.

Paid for and in partnership with Lonza Small Molecules

Reducing the complexity of drug development through integrated services

Biotech companies face risks in drug development. Partnering with a CDMO that provides an integrated offering can reduce the potential for delays and greater expenses.

Belong.Life launches Tara - an AI SaaS matching cancer patients to clinical trials

Built upon seven years of real-world patient journey data, Belong.Life has recently announced the launch of its software as a service (SaaS)-based conversational artificial intelligence (AI) cancer clinical trial matching platform.